Development and responses of brain metastases during treatment with trastuzumab emtansine (T-DM1) for HER2 positive advanced breast cancer: A single institution experience

Okines, A; Irfan, T; Khabra, K; Smith, I; O'Brien, M; Parton, M; Noble, J; Stanway, S; Somaiah, N; Ring, A; Johnston, S; Turner, N

Okines, A (reprint author), Royal Marsden NHS Fdn Trust, London, England.

BREAST JOURNAL, 2018; 24 (3): 253

Abstract

Ado-trastuzumab emtansine (T-DM1) is an antibody-drug conjugate that does not cross an intact blood-brain barrier. In the EMILIA trial of T-DM1 vs cap......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索